Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. S1 Data

Gombe, B; Streatfield, C; Leal, L; Opio, S; Joseph, S; Weber, J; Hare, J

; Kaleebu, P

and Serwanga, J (2022). Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. S1 Data. [Dataset]. PLOS ONE. https://doi.org/10.1371/journal.pone.0275927.s001

Copy

Data supporting the analyses outlined in "Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial".

Keywords

Enzyme-linked immunoassays; Antibodies; HIV vaccines; Vaccine development; HIV; Coatings; Viral vaccines; Virus testing

Item Type	Dataset
Resource Type	Resource Type Resource Description Dataset Quantitative
Capture method	Unknown
Date	3 November 2022
Language(s) of written materials	English
Creator(s)	Gombe, B; Streatfield, C; Leal, L; Opio, S; Joseph, S; Weber, J; Hare, J; Kaleebu, P and Serwanga, J
LSHTM Faculty/Department	MRC/UVRI and LSHTM Uganda Research Unit
Participating Institutions	London School of Hygiene & Tropical Medicine, London, United Kingdom
Date Deposited	09 Dec 2022 11:41
Last Modified	18 Sep 2025 13:15
Publisher	PLOS ONE